Malignant glioma arising at the site of an excised cerebellar hemangioblastoma after irradiation in a von Hippel-Lindau disease patient.
We describe herein a malignant glioma arising at the site of the resected hemangioblastoma after irradiation in a patient with von Hippel-Lindau disease (VHL). The patient was a 25 year-old male with multiple hemangioblastomas at the cerebellum and spinal cord, multiple pancreatic cysts and a renal cell carcinoma; he was diagnosed as having VHL disease. The largest hemangioblastoma at the right cerebellar hemisphere was completely removed, and he received high-dose irradiation postoperatively. The tumor recurred at the same site 7 years later, which was a malignant glioma with no evidence of hemangioblastoma. The malignant glioma showed molecular genetic profiles of radiation-induced tumors because of its diffuse p53 immunostaining and the loss of p16 immunoreactivity. The genetic study to find the loss of heterozygosity (LOH) of VHL gene revealed that only the cerebellar hemangioblastoma showed allelic losses for the gene. To the best of our knowledge, this report is the first to show a malignant glioma that developed in a patient with VHL disease after radiation therapy at the site of an excised hemangioblastoma. This report also suggests that radiation therapy should be performed very carefully in VHL patients with hemangioblastomas.
Myong
Na-Hye
NH
Department of Pathology, Dankook University College of Medicine, Cheonan, Korea. myongnh@dankook.ac.kr
Park
Bong-Jin
BJ
D000328:Adult; D002528:Cerebellar Neoplasms / Q000150:complications / Q000601:surgery*; D005910:Glioma / Q000175:diagnosis* / Q000209:etiology*; D018325:Hemangioblastoma / Q000150:complications / Q000601:surgery*; D006801:Humans; D008297:Male; D011878:Radiotherapy / Q000009:adverse effects*; D006623:von Hippel-Lindau Disease / Q000150:complications / Q000532:radiotherapy*